Show
Sort by
-
Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity
-
Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment
-
Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition
-
Comparison of the anti-human citrullinated fibrinogen antibodies assayed by ELISA with 2 other ACPA assays: Diagnostic value and agreement between assays
-
Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays
-
Polymorphisms in the ficolin 1 gene (Fcn1) are associated with susceptibility to the development of rheumatoid arthritis
-
Comparison of Machine Learning models for prediction of dose increase in patients with rheumatoid arthritis
-
Feature selection in the prediction of Infliximab dose increase
-
Comparing statistics with machine learning models to predict dose increase of infliximab for rheumatoid arthritis patients
-
CARD15 polymorphisms are associated with anti-Saccharomyces cerevisiae antibodies in caucasian Crohn's disease patients